BioSpace News Archive

Protech Home Medical Corp., a healthcare services company with operations in the U.S., is pleased to announce preliminary financial results for the second quarter of 2020, ending March 31, 2020.

Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the first quarter ended March 31, 2020, after the market close, and will host a corporate update conference call and webcast on Tuesday, May 5, 2020, at 4:30 PM Eastern Time. Conference Call Details Tuesday, May 5, at 4:30 PM Eastern Time / 1:30 PM Pacific Time

InterShunt Technologies, Inc., an early stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced the formation of a Scientific Advisory Board and successful first meeting.

Company marks a milestone in its growth by shipping global system No. 8,500 to UTHealth. [28-April-2020] HOUSTON , April 28, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, confirmed it shipped its 8,500th system worldwide, a uMI 550 digital PET/CT destined for The University of Texas Health Science Cente

-- Conference Call Scheduled for 11:00 a.m. ET -- -- Key U.S. Regulatory Milestones Remain on Track, Including May 25, 2020

The reusable Personal Protective Equipment masks are now in production in Marena’s FDA approved, Georgia facility that has made post-surgical medical device gear for over twenty-five years

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2020 financial results after the market close on Tuesday, May 5 , 2020.

Phase 1 Dose-Escalation Trial in Therapy-Refractory Solid Tumors to Begin in 2020

IVERIC bio, Inc. announced that it will report its first quarter 2020 financial and operating results on Wednesday, May 6, 2020.

Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced that the Company has taken significant steps to reduce overhead and conserve liquidity as it continues operations while assessing strategic options.